Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Classement en actions #827
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Prix de l'action
$71.46
Capitalisation boursière
$29.96B
Changement (1 jour)
-0.04%
Changement (1 an)
-51.01%
Pays
US
Échange Zoetis Inc. (ZTS)

Catégorie

Healthcare
EPS pour Zoetis Inc. (ZTS)
EPS au June 2026 TTM : $6.08
Selon les derniers rapports financiers et le cours de l'action de Zoetis Inc., l’EPS actuel de la société (TTM) est de $6.08. À la fin de 2024, la société avait un EPS de $5.47 une augmentation par rapport à celui de 2023, qui était de $5.08.
Historique de l'EPS de Zoetis Inc. de 2009 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $6.08 0.83%
2025 $6.03 10.24%
2024 $5.47 7.68%
2023 $5.08 12.64%
2022 $4.51 5.13%
2021 $4.29 24.71%
2020 $3.44 9.55%
2019 $3.14 6.08%
2018 $2.96 68.18%
2017 $1.76 6.02%
2016 $1.66 144.12%
2015 $0.68 -41.38%
2014 $1.16 14.85%
2013 $1.01 16.09%
2012 $0.87 70.59%
2011 $0.51 121.74%
2010 $0.23 -209.52%
2009 $-0.21 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 390.95%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 42.27%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -41.61%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 235.35%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -79.28%
US